drugset / Trial / NCT06903715
A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)
NaSingle-groupOpen-labelBasic science
Summary
Researchers designed belzutifan, the study medicine, to treat certain kinds of cancer. The goal of this study is to learn what happens to belzutifan in a healthy person's body over time when taken, by mouth, as a tablet. Researchers will learn what happens when belzutifan is taken alone and when it is taken after several days of treatment with phenytoin.
Timeline
- Start
- 2025-03-28
- Primary completion
- 2025-05-08
- Completion
- 2025-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belzutifan | Small molecule | — | Oral |
| Subject | Phenytoin | Unknown | — | Oral |
Indications
No indication recorded.